Professor Nutt’s talk explores the contributions of politics and science to decision making about alcohol and other drugs. Professor Nutt reveals how evidential uncertainties are used to strengthen the political rhetoric and how this process has led to the denial of clinical research and utility to the great detriment of millions of people for many …
Dr Ben Sessa – MDMA for Alcohol Use Disorder Dr Ben Sessa presents the preliminary data in an ongoing open-label safety and tolerability proof of concept study exploring the potential role for 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in treating patients with alcohol use disorder. At this stage, seven participants have completed the full 8-week MDMA-assisted psychotherapy course, …
Drug Science notice of support for joint NGO statement ‘Towards science-based scheduling of Cannabis sativa and other controlled herbal medicines’. Furthermore, Drug Science is especially pleased with this result as it was our cannabis pre-review and presentation to the expert committee in 2016 that initiated this whole process that has, at last, led to this …
A Drug Science response to the Advisory Council on the Misuse of Drugs (ACMD) Report: Cannabis-based products for medicinal use (CBPMs) in humans (November 2020) In February 2019 the then-Home secretary commissioned the ACMD to conduct a longer-term review of cannabis-based products for medicinal use in humans. The aim was to assess the impact of …
Public and scientific interest into psychedelic drugs has grown steadily over much of the last two decades, before an exponential increase in recent years. We contend that 2019, in particular, involved myriad notable changes in the science, industry, and deregulation of psychedelic drugs. However, it is becoming increasingly difficult for professionals to keep up-to-date on …
Drug Science Patron Lord Nic Rea, hosted Drug Science committee members, trustees, and community supporters at House of Lords on Wednesday, celebrating ten years of achievements, and new initiatives in medical cannabis and psychedelic research. In the beautiful Cholmondeley Room of Westminster Palace, 150 of Drug Science’s supporters heard CEO David Badcock welcome guests and …
Prof. Adam Winstock – Global Drug Survey 2019 As the tide of cannabis regulatory reform wafts through North America and beyond, it strikes me that the cannabis legalisation lobby started from a strong position. The weight of evidence and cogent arguments at their disposal to counter the totally unhelpful criminalisation of cannabis users was enormous. …
